Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

SeaStar Medical Holding (ICU) Shares Outstanding (2023 - 2025)

Historic Shares Outstanding for SeaStar Medical Holding (ICU) over the last 3 years, with Q3 2025 value amounting to $34.1 million.

  • SeaStar Medical Holding's Shares Outstanding rose 70904.58% to $34.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $34.1 million, marking a year-over-year increase of 70904.58%. This contributed to the annual value of $6.0 million for FY2024, which is 19647.89% up from last year.
  • Per SeaStar Medical Holding's latest filing, its Shares Outstanding stood at $34.1 million for Q3 2025, which was up 70904.58% from $17.3 million recorded in Q2 2025.
  • SeaStar Medical Holding's Shares Outstanding's 5-year high stood at $34.1 million during Q3 2025, with a 5-year trough of $531861.0 in Q1 2023.
  • For the 3-year period, SeaStar Medical Holding's Shares Outstanding averaged around $7.4 million, with its median value being $3.2 million (2024).
  • Over the last 5 years, SeaStar Medical Holding's Shares Outstanding had its largest YoY gain of 70904.58% in 2025, and its largest YoY loss of 19594.1% in 2025.
  • Quarter analysis of 3 years shows SeaStar Medical Holding's Shares Outstanding stood at $2.0 million in 2023, then surged by 196.48% to $6.0 million in 2024, then skyrocketed by 470.44% to $34.1 million in 2025.
  • Its Shares Outstanding stands at $34.1 million for Q3 2025, versus $17.3 million for Q2 2025 and $9.3 million for Q1 2025.